Management of Patent Ductus Arteriosus in Preterm Infants-Where Do We Stand? A UK National Perspective

Yajamanyam, Phani Kiran; Kanani, Anand; Rasiah, SV

doi:10.1111/chd.12170

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2018

2020

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although some articles reported that paracetamol was safer than indomethacin in terms of side effects (24,34,52), our results did not directly produce such results. The main reason was that fewer studies were included.…”

Section: Discussioncontrasting

confidence: 86%

Efficacy and Safety of Paracetamol for Patent Ductus Arteriosus Closure in Preterm Infants: An Updated Systematic Review and Meta-Analysis

Xiao

Liu

et al. 2020

Front. Pediatr.

View full text Add to dashboard Cite

Section: Discussioncontrasting

confidence: 86%

Efficacy and Safety of Paracetamol for Patent Ductus Arteriosus Closure in Preterm Infants: An Updated Systematic Review and Meta-Analysis

Xiao

Liu

et al. 2020

Front. Pediatr.

View full text Add to dashboard Cite

Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus

Harris

Dixon

et al. 2018

Eur J Pediatr

View full text Add to dashboard Cite

Day 3 NTproBNP is a useful biomarker to predict HsPDA and may be a valuable tool in future trial design. What is Known: • NTproBNP is a cardiac hormone used to diagnose and monitor cardiac dysfunction in adults and has been shown to be higher in premature infants with haemodynamically significant ductus arteriosus (HsPDA). What is new: • NTproBNP is highly predictive of ultrasound-defined HsPDA and may be a useful tool for further triage • Early NTproBNP higher in infants who develop severe BPD and with renal impairment but not affected by gestational age, recent exposure to hypoxia or haemoglobin levels while late levels unexpectedly higher in those without BPD or HsPDA.

show abstract

Management of Patent Ductus Arteriosus in Preterm Infants-Where Do We Stand? A UK National Perspective

Cited by 2 publications

References 5 publications

Efficacy and Safety of Paracetamol for Patent Ductus Arteriosus Closure in Preterm Infants: An Updated Systematic Review and Meta-Analysis

Efficacy and Safety of Paracetamol for Patent Ductus Arteriosus Closure in Preterm Infants: An Updated Systematic Review and Meta-Analysis

Factors affecting N-terminal pro-B-type natriuretic peptide levels in preterm infants and use in determination of haemodynamic significance of patent ductus arteriosus

Contact Info

Product

Resources

About